Willingness to take less medication for type 2 diabetes among older patients: The Diabetes & Aging Study.

Autor:	Haider, Shanzay, Parker, Melissa M., Huang, Elbert S., Grant, Richard W., Moffet, Howard H., Laiteerapong, Neda, Jain, Rajesh K., Liu, Jennifer Y., Lipska, Kasia J., Karter, Andrew J.
Předmět:	PATIENT compliance CROSS-sectional method DISEASE duration GLYCOSYLATED hemoglobin HEALTH status indicators RESEARCH funding STATISTICAL sampling AGE distribution DESCRIPTIVE statistics POLYPHARMACY INSULIN SURVEYS TYPE 2 diabetes PATIENT-professional relations DRUGS COMORBIDITY HYPOGLYCEMIA SYMPTOMS OLD age
Zdroj:	Journal of the American Geriatrics Society; Jul2024, Vol. 72 Issue 7, p1985-1994, 10p
Abstrakt:	Background: To examine the willingness of older patients to take less diabetes medication (de‐intensify) and to identify characteristics associated with willingness to de‐intensify treatment. Methods: Survey conducted in 2019 in an age‐stratified, random sample of older (65–100 years) adults with diabetes on glucose‐lowering medications in the Kaiser Permanente Northern California Diabetes Registry. We classified survey responses to the question: "I would be willing to take less medication for my diabetes" as willing, neutral, or unwilling to de‐intensify. Willingness to de‐intensify treatment was examined by several clinical characteristics, including American Diabetes Association (ADA) health status categories used for individualizing glycemic targets. Analyses were weighted to account for over‐sampling of older individuals. Results: A total of 1337 older adults on glucose‐lowering medication(s) were included (age 74.2 ± 6.0 years, 44% female, 54.4% non‐Hispanic white). The proportions of participants willing, neutral, or unwilling to take less medication were 51.2%, 27.3%, and 21.5%, respectively. Proportions of willing to take less medication varied by age (65–74 years: 54.2% vs. 85+ years: 38.5%) and duration of diabetes (0–4 years: 61.0% vs. 15+ years: 44.2%), both p < 0.001. Patients on 1–2 medications were more willing to take less medication(s) compared with patients on 10+ medications (62.1% vs. 46.6%, p = 0.03). Similar proportions of willingness to take less medications were seen across ADA health status, and HbA1c. Willingness to take less medication(s) was similar across survey responses to questions about patient‐clinician relationships. Conclusions: Clinical guidelines suggest considering treatment de‐intensification in older patients with longer duration of diabetes, yet patients with these characteristics are less likely to be willing to take less medication(s). See related Editorial by Pilla and Maruthur [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text